Galen Health
Techstars '25Pittsburgh, US · 1 known investors
Galen builds causal, computational models of living cells ("virtual cells") that predict how a cell behaves under interventions such as genetic changes before lab experiments are run. It focuses initially on durability and exhaustion in engineered T cell therapies, serving scientists and drug developers working on cell therapies.